¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022 ´ëÇÑÄ¡¸ÅÇÐȸ Ãá°è Çмú´ëȸ : 2022-04-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022 ´ëÇÑÄ¡¸ÅÇÐȸ Ãá°è Çмú´ëȸ : 2022-04-16
±³À°ÀÏÀÚ : 2022-04-16
±³À°Àå¼Ò : ÇÏÀ̺긮µå (Àå¼Ò: ¹é¹ü±è±¸±â³ä°ü)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) 2022 ´ëÇÑÄ¡¸ÅÇÐȸ Ãá°è Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÄ¡¸ÅÇÐȸ 
´ã´çÀÚ : ±èÁÖ¿Á
¿¬¶ôó : 02-587-7462  
À̸ÞÀÏ : secretkda@thedementia.co.kr      
±³À°Á¾·ù : ½Å°æ°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í ÀϹÝȸ¿ø 2¸¸¿ø, Á¤È¸¿ø 3¸¸¿ø, ºñȸ¿ø 5¸¸¿ø (ÇöÀåµî·Ï ¾øÀ½)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 08:50~09:00 Opening remarks  () 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:00~09:20 Genetics Update  ¹Ú¿µÈ£(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:20~09:40 Microbiome Update  ÀÌ°ÇÈ£(Á¶¼±´ëÇб³) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:40~10:05 The Gantenerumab Global Development Program for Alzheimer''''s Disease  Scott Schobel(Roche) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:05~10:30 Clinical, Biomarker, and Safety Update BAN2401-G000-201, the Lecanemab Phase 2 Proof of Concept Study and Open Label Extension  Chad Swanson(Eisai) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:30~10:55 Future for the development of Alzheimer¡¯s disease modifiers clinical trial results of donanemab  Ena Oru(Lilly) 
È޽Ġ04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:55~11:20 Coffee Break  () 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:20~12:00 Can we prevent aging?  ÇѼ³Èñ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:00~12:40 Current and future direction of AD biomarkers  Gill Rabinovici(UCSF) 
±âŸ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:40~13:00 ÃÑȸ  () 
½Ä»ç 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 13:00~14:20 Lunch ¹× Poster session  () 
Åä·Ð 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 14:20~15:20 Pannel discussion for Current Issues : Aducanumab! Is this new hope for Alzhiemer's?  ¹Ú±âÇü(°¡ÃµÀÇ´ë) 
È޽Ġ04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 15:20~15:30 Coffee Break  () 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 15:30~15:50 Development of tau-targeted therapeutic strategy for dementia  ±èÀ±°æ(KIST) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 15:50~16:10 Nanobiosensor technology for serological biomarker detection of neurodegenerative disease  È²±³¼±(°æÈñÀÇ´ë) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 16:10~16:30 Genetic factors of Alzheimer's disease in the Korean population  ±èÈñÁø(¼º±Õ°üÀÇ´ë) 
È޽Ġ04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 16:30~16:40 Coffee Break  () 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 16:40~17:00 Clinical usefulness and need of blood biomarkers in the diagnosis and follow-up of AD  °í¼ºÈ£(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 17:00~17:20 Introduction of Currently Available Blood Based Biomarker of AD  ÀåÀç¿ø(°­¿øÀÇ´ë) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room A) 17:20~17:40 Clinical application of AD blood biomarker: expectations & concerns  ½É¿ë¼ö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 15:30~15:50 Clinical application of A.I. in Dementia  ¼­»ó¿ø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 15:50~16:10 A.I in Neuroimaging of AD  Á¤¿ë(KAIST) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 16:10~16:30 Dementia big data platforms in the UK, Europe and Korea  ±èÄ¡Çå(ÇѸ²ÀÇ´ë) 
È޽Ġ04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 16:30~16:40 Coffee Break  () 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 16:40~17:00 µðÁöÅÐ Ä¡·áÁ¦ÀÇ Çö¾È°ú ¹Ì·¡  ÇÑ¿µ¹Î ÁÖ¹«°ü(½ÄÇ°ÀǾàÇ°¾ÈÀüó) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 17:00~17:20 µðÁöÅÐ Ä¡·áÁ¦ °³¹ß°ú ÇâÈÄ Àü¸Á  ±èÁø¿ì ´ëÇ¥(¢ßÇÏÀÌ) 
±³À°½Ã°£ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ (Room B) 17:20~17:40 µðÁöÅÐÇコÄɾî/µðÁöÅÐÄ¡·áÁ¦´Â ¾î¶»°Ô ºñÁö´Ï½º°¡ µÇ´Â°¡  ±èÄ¡¿ø »ó¹«(Ä«Ä«¿Àº¥Ã³½º) 
±âŸ 04-16 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 17:40~17:50 Closing remarks ¹× ½Ã»ó½Ä  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022 ´ëÇÑÄ¡¸ÅÇÐȸ Ãá°è Çмú´ëȸ : 2022-04-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2022³âµµ Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ÀΰÝÀå¾Ö Á¤½ÅÄ¡·á ¿öÅ©¼¥ 3 : 2022-04-16
´ÙÀ½±Û °æºÏ´ëÇб³º´¿ø ¸¶ÃëÅëÁõÀÇÇаú ¿öÅ©¼¥ : 2022-04-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
240 ¼­¿ï ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ International Colorectal Research Summit 2018 : 2018-09-09 0 474 2018-07-28
239 ºÎ»ê µ¿¾Æ´ëÇб³ÀÇ·á¿ø Á¦ 1ȸ µ¿¾Æ´ëÇб³ Á¤Çü¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-09 0 1,159 2018-07-28
238 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2018 SNU Orthopaedic Update(III) Foot & Ankle : 2018-09-09 0 942 2018-07-28
237 ºÎ»ê ¼¼ºê¶õ½ºº´¿ø 70Â÷ fresh cadaver shoulder arthroscopy workshop : 2018-09-09 0 466 2018-07-28
236 ºÎ»ê ´ëÇѽÅÀåÇÐȸ ºÎ¿ï°æ Ç÷¾×Åõ¼® ½ÉÆ÷Áö¾ö : 2018-09-09 0 1,229 2018-07-28
235 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø °íÀ§Çè »ê¸ð/½Å»ý¾ÆÀÇ Ã³Ä¡ ¹× °£È£ : 2018-09-09 0 465 2018-07-28
234 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¼¼ºê¶õ½º ¾È°ú 133Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2018-09-09 0 635 2018-07-28
233 °æ±â ¼øõÇâ´ëÇб³ºÎõº´¿ø ³»½Ã°æ ÃÊÀ½ÆÄ ¶óÀÌºê ½ÉÆ÷Áö¾ö 2018 : 2018-09-09 0 986 2018-07-28
232 ¼­¿ï 2018 ´ëÇѹ̿뼺Çü·¹ÀÌÀúÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-09 0 3,325 2018-07-28
231 ¼­¿ï Á¦ 19ȸ ´ëÇÑÅõ¼®Çùȸ Ãß°è ½ÉÆ÷Áö¿ò : 2018-09-09 0 867 2018-07-28
230 ¼­¿ï ÀÌ´ë¸ñµ¿º´¿ø »êºÎÀΰú Áö¿ªÀÇ»ç °£´ãȸ : 2018-09-08 0 688 2018-07-28
229 Á¦ÁÖ ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ CAMP(Chronic Airway Management in Pulmonary disease) ½ÉÆ÷Áö¾ö : 2018-09-08 0 637 2018-07-28
228 ¼­¿ï 2018³âµµ ´ëÇѺñ¸¸ÇÐȸ ±¹Á¦Çмú´ëȸ(ICOMES 2018) - 09/08 : 2018-09-08 0 611 2018-07-28
227 ¼­¿ï 2018³â À»Áö´ëÇб³ À»Áöº´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-08 0 1,204 2018-07-28
226 ¼­¿ï 2018³â ´ëÇѳëÀθ¶ÃëÅëÁõÇÐȸ Çмú´ëȸ : 2018-09-08 0 581 2018-07-28
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷